missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TOR2A Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA584862
This item is not returnable.
View return policy
Description
Immunogen sequence: AIFIFISNTG GEQINQVALE AWRSRRDREE ILLQELEPVI S Highest antigen sequence indentity to the following orthologs: Rat - 90%, Mouse - 90%.
Salusins are multifunctional bioactive peptides discovered by bioinformatics analyses of a full-length cDNA library. Salusin alpha and salusin beta are related peptides of 28 and 20 amino acids that were recently characterized. These peptides are considered to be biosynthesized from preprosalusin, an alternative-splicing product of the torsion dystonia-related gene (TOR2A), after frameshift reading and digestion at dibasic amino acids. Salusin alpha has recently been shown to be involved in atherosclerosis; it potently suppresses acyl-CoA:cholesterol acyltransferase-1 which stores cholesterol ester converted from free cholesterol in macrophages, thereby reducing human macrophage foam cell formation.
Specifications
| TOR2A | |
| Polyclonal | |
| Unconjugated | |
| TOR2A | |
| HEMBA1005096; Prosalusin; PSEC0218; Salusin-alpha; Salusin-beta; TOR2A; TORP1; Torsin family 2 member A; torsin family 2, member A; torsin-2A; Torsin-related protein 1; UNQ6408/PRO21181 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 27433 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q5JU69 | |
| TOR2A | |
| Recombinant protein corresponding to Human TOR2A. Recombinant protein control fragment (Product #RP-108581). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction